Get the Stockscreener App
38.92
2.39%
-1.02
Rigel Pharmaceuticals stock is traded at $38.92, with a volume of 68,119.
It is down -2.39% in the last 24 hours and up +45.30% over the past month.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
See More
Previous Close:
$39.94
Open:
$39.32
24h Volume:
68,119
Relative Volume:
0.10
Market Cap:
$699.56M
Revenue:
$116.88M
Net Income/Loss:
$-25.09M
P/E Ratio:
-278.00
EPS:
-0.14
Net Cash Flow:
$-20.74M
1W Performance:
+7.93%
1M Performance:
+45.30%
6M Performance:
+113.15%
1Y Performance:
+42.23%
1-Day Range:
$38.58
$39.67
1-Week Range:
$34.00
$40.06
52-Week Range:
$14.63
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
Name
Rigel Pharmaceuticals
Sector
Industry
Phone
650-624-1100
Address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Compare RIGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
39.00 | 724.96M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.33 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.75 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.37 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
890.25 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
373.75 | 41.77B | 4.56B | -176.77M | 225.30M | -1.7177 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-03-23 | Resumed | Piper Sandler | Neutral |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Jun-08-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-23-22 | Initiated | B. Riley Securities | Neutral |
| Nov-09-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-15-19 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-26-19 | Resumed | JP Morgan | Overweight |
| Mar-01-19 | Reiterated | Cantor Fitzgerald | Overweight |
| Aug-27-18 | Initiated | Citigroup | Buy |
| May-02-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Resumed | Piper Jaffray | Overweight |
| Dec-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-06-17 | Resumed | H.C. Wainwright | Buy |
| Mar-09-17 | Reiterated | H.C. Wainwright | Buy |
| Aug-31-16 | Reiterated | H.C. Wainwright | Buy |
| Aug-30-16 | Reiterated | Piper Jaffray | Overweight |
| Jul-13-16 | Initiated | H.C. Wainwright | Buy |
| Jun-13-16 | Initiated | Piper Jaffray | Overweight |
| Apr-22-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-08-13 | Reiterated | Stifel | Buy |
| Nov-29-12 | Initiated | UBS | Neutral |
| Nov-06-12 | Reiterated | Oppenheimer | Outperform |
| Mar-26-12 | Initiated | Canaccord Genuity | Hold |
| Dec-10-10 | Downgrade | MP Advisors | Outperform → Market Perform |
View All
Rigel Pharmaceuticals Stock (RIGL) Latest News
How Rigel Pharmaceuticals Inc. stock performs in high volatility marketsTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
What insider trading reveals about Rigel Pharmaceuticals Inc. stockJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleJuly 2025 Recap & Community Verified Trade Signals - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock sustain dividend payoutsTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Applying big data sentiment scoring on Rigel Pharmaceuticals Inc.July 2025 Breakouts & Real-Time Volume Analysis - newser.com
How Rigel Pharmaceuticals Inc. stock responds to policy changesJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Can a trend reversal in Rigel Pharmaceuticals Inc. lead to recoveryJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Rigel (Nasdaq: RIGL) to present in London at Jefferies Healthcare Conference - Stock Titan
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% - simplywall.st
Will earnings trigger a reversal in Rigel Pharmaceuticals Inc.2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Rigel Pharmaceuticals Joins Elite List Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Will Rigel Pharmaceuticals Inc. stock attract ESG investorsAnalyst Downgrade & Daily Price Action Insights - newser.com
Will Rigel Pharmaceuticals Inc. (RI2) stock split increase liquidity2025 Price Momentum & Reliable Entry Point Trade Alerts - newser.com
Rigel Pharmaceuticals Inc Stock Analysis and ForecastMarket Profile Overview & Low Risk Capital Growth - earlytimes.in
Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Short Interest & Real-Time Volume Triggers - newser.com
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Will Rigel Pharmaceuticals Inc. stock reach Wall Street targetsWeekly Gains Report & Entry Point Strategy Guides - newser.com
Detecting price anomalies in Rigel Pharmaceuticals Inc. with AIJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Candlestick signals on Rigel Pharmaceuticals Inc. stock todayInflation Watch & Weekly Momentum Stock Picks - newser.com
Trading Systems Reacting to (RIGL) Volatility - news.stocktradersdaily.com
Can Rigel Pharmaceuticals Inc. stock hit analyst price targetsPortfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
What momentum shifts mean for Rigel Pharmaceuticals Inc.Weekly Market Report & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-11-09 21:25:18 - newser.com
Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Record Q3 Results and Raised 2025 Outlook - Yahoo Finance
Measuring Rigel Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Why Rigel Pharmaceuticals Inc. stock could see breakout soonJuly 2025 PostEarnings & Pattern Based Trade Signal System - newser.com
Published on: 2025-11-09 05:40:52 - newser.com
Published on: 2025-11-09 04:34:19 - newser.com
Is Rigel Pharmaceuticals Inc. stock recession proof2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance - simplywall.st
Rigel Pharmaceuticals Stock (RIGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):